Placebo for efgartigimod, ARGX-113, Vyvgart 20 mg/mL concentrate for solution for infusion
ARGX-113-2402
Phase 3 small_molecule active
Quick answer
Placebo for efgartigimod, ARGX-113, Vyvgart 20 mg/mL concentrate for solution for infusion for Primary Immune thrombocytopenia (ITP) is a Phase 3 program (small_molecule) at Argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Argenx
- Indication
- Primary Immune thrombocytopenia (ITP)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active